Overview

Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer

Status:
Completed
Trial end date:
2019-08-29
Target enrollment:
Participant gender:
Summary
This study evaluates the diagnostic performance and safety of 18F-DCFPyL (PyL) PET/CT imaging in patients with suspected recurrence of prostate cancer who have negative or equivocal findings on conventional imaging.
Phase:
Phase 3
Details
Lead Sponsor:
Progenics Pharmaceuticals, Inc.